US22407B1089 - COYA (XNAS)
Coya Therapeutics, Inc. - Common Stock Aktie
6,29 USD
Aktuelle Kurse von Coya Therapeutics, Inc. - Common Stock
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
COYA
|
USD
|
19.09.2024 21:59
|
6,29 USD
| 6,06 USD | 3,80 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -0,63 % | 12,32 % | -7,50 % | -37,54 % | 53,79 % | 37,64 % |
Firmenprofil zu Coya Therapeutics, Inc. - Common Stock Aktie
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an allogeneic Treg exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.
Unternehmensdaten zur Coya Therapeutics, Inc. - Common Stock Aktie
Name Coya Therapeutics, Inc. - Common Stock
Firma Coya Therapeutics, Inc.
Symbol COYA
Website https://www.coyatherapeutics.com
Heimatbörse
NASDAQ
ISIN US22407B1089
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Howard Berman Ph.D.
Marktkapitalisierung 91 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 5850 San Felipe Street, 77057 Houston
IPO Datum 2022-12-29
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | COYA |
Weitere Aktien
Investoren die Coya Therapeutics, Inc. - Common Stock halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024